Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/RYVU-THERAPEUTICS-S-A-19156501/news/Ryvu-Therapeutics-prasentiert-praklinische-Daten-zu-RVU120-und-synthetischen-Letalitatsprogrammen-46102454/?utm_source=whatsapp&utm_medium=social&utm_campaign=share